原发性干燥综合征抗RNP抗体阳性与更活跃的疾病及更频繁的肌肉和肺部受累相关
该研究比较了抗RNP抗体阳性的原发性干燥综合征(pSS)患者与抗体阴性患者的临床和生物学特征。结果显示,抗RNP阳性患者发病年龄更低、EULAR干燥综合征疾病活动指数更高,更常出现全身症状、肌炎和肺部受累,γ球蛋白水平更高,抗SSA抗体更常见,但灶性淋巴细胞性涎腺炎(焦点评分≥1)较少见。
要点
- 抗RNP阳性pSS患者发病年龄更低(中位41.0 vs 50.0岁,p=0.01),疾病活动指数更高(中位8.0 vs 3.0,p<0.01)。
- 抗RNP阳性与更频繁的肌炎(19.0% vs 2.3%,p<0.01)和肺部受累(19.0% vs 5.7%,p=0.04)相关。
- 抗RNP阳性患者γ球蛋白更高(中位22.5 vs 13 g/L,p<0.01),抗SSA抗体更常见(90.5% vs 67.1%,p=0.03),但灶性淋巴细胞性涎腺炎较少见(66.7% vs 85.5%,p=0.03)。
核心结论
- 抗RNP抗体阳性的pSS患者表现出更活跃的系统性疾病,肌肉和肺部受累更频繁,γ球蛋白水平升高。
研究设计与样本
- 回顾性数据库研究,从法国国家参考中心数据库检索符合ACR/EULAR 2016 pSS标准、抗RNP抗体阳性且无其他结缔组织病诊断和抗dsDNA抗体的患者,与抗Sm、抗RNP和抗dsDNA抗体均阴性的其他pSS患者比较。
主要发现
- 抗RNP阳性患者发病年龄中位数更低(41.0 vs 50.0岁,p=0.01),纳入时EULAR干燥综合征疾病活动指数中位数更高(8.0 vs 3.0,p<0.01)。
- 抗RNP阳性患者全身症状(14.3% vs 0.01%,p<0.01)、肌炎(19.0% vs 2.3%,p<0.01)和肺部受累(19.0% vs 5.7%,p=0.04)更频繁。
- 抗RNP阳性患者γ球蛋白中位数更高(22.5 vs 13 g/L,p<0.01),抗SSA抗体更常见(90.5% vs 67.1%,p=0.03),灶性淋巴细胞性涎腺炎(焦点评分≥1)较少见(66.7% vs 85.5%,p=0.03)。
- 限制于抗SSA阳性患者分析时,抗RNP阳性与相同的临床生物学特征相关,但肺部受累除外。
关键数值与推荐
- pSS诊断符合ACR/EULAR 2016标准。
- 抗RNP阳性组21例,抗RNP阴性组446例。
临床怎么用
- 对pSS患者检测抗RNP抗体可能有助于识别具有更活跃系统性疾病及肌肉、肺部受累风险更高的亚群。
局限性
- 研究为回顾性设计,样本量有限(抗RNP阳性组仅21例),可能影响结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe and compare the clinical and biological characteristics of subjects with primary Sjögren's syndrome (pSS) with and without anti-RNP antibodies. METHODS: Patients fulfilling the American College of Rheumatology (ACR)/EULAR 2016 criteria for pSS and having anti-RNP antibodies, without other connective tissue disease diagnosed and no anti-dsDNA antibodies were retrieved from the database from our French National Reference Center. These patients were compared with all other patients with pSS with negative anti-Sm, anti-RNP and anti-dsDNA antibodies. RESULTS: Overall, 21 patients with pSS positive for anti-RNP antibodies and 446 negative for anti-RNP antibodies were retrieved. Anti-RNP-positive patients had a lower median age at onset of pSS symptoms (41.0 vs 50.0 years, p=0.01), a higher median EULAR Sjögren's syndrome disease activity index at inclusion (8.0 vs 3.0, p<0.01), more frequently constitutional symptoms (14.3% vs 0.01%, p<0.01), myositis (19.0% vs 2.3%, p<0.01) and pulmonary (19.0% vs 5.7%, p=0.04) involvement. Moreover, anti-RNP-positive patients had higher median gammaglobulin levels (22.5 vs 13 g/L, p<0.01), more frequently anti-SSA antibodies (90.5% vs 67.1%, p=0.03), but less frequent lymphocytic sialadenitis with a focus score ≥1 (66.7% vs 85.5%, p=0.03). If the analysis is restricted to anti-SSA-positive patients, anti-RNP positivity is associated with the same clinicobiologic features except the pulmonary involvement. CONCLUSION: Patients with pSS with anti-RNP antibodies displayed a more active systemic disease, with more frequent muscular and pulmonary involvement, and increased gammaglobulin level, compared with anti-RNP-negative patients.
引用
- Abbara S, Seror R, Henry J, et al. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open. 2019. PMID: 31673417. doi:10.1136/rmdopen-2019-001033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。